Septerna, Inc. · NASDAQ:SEPN
Long Daniel D. sold 3,334 Septerna, Inc. shares (Form 4)
Traded Aug 3, 2026 · Filed Aug 5, 2026
On Aug 3, 2026, Long Daniel D. (SVP, Drug Discovery) sold 3,334 Septerna, Inc. shares at an average US$34.47 for US$115K under a trading plan, leaving 96,412 shares. Filed Aug 5, 2026 (Form 4).
- Sold
- 3,334 shares
- Price
- US$34.47 average (US$33.98 to US$34.68)
- Value
- US$115K
- Holding after
- 96,412 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, Drug Discovery
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Option exercise | 1,816 | US$2.76 | 98,228 | Direct |
| Aug 3, 2026 | Common Stock | Option exercise | 1,518 | US$2.76 | 99,746 | Direct |
| Aug 3, 2026 | Common Stock | Sale | 1,000 | US$33.98 | 98,746 | Direct |
| Aug 3, 2026 | Common Stock | Sale | 2,334 | US$34.68 | 96,412 | Direct |
Source
Related
- Septerna, Inc.
- Long Daniel D.
- Septerna, Inc. shareholders
- Form 4 · Long Daniel D. · Sep 3, 2026
- Form 4 · Long Daniel D. · Jul 2, 2026
- Form 4 · Long Daniel D. · Jun 24, 2026
- Form 4 · Third Rock Ventures GP VI, L.P. · Aug 14, 2026
- Form 4 · Shah Rajeev M. · Aug 14, 2026
- Schedule 13G/A · Driehaus Capital Management LLC · Aug 14, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Bhatt Elizabeth · Aug 13, 2026